Hemophilia Federation of America/LinkedIn
Mar 28, 2026, 19:02
Marking a Century of Progress in von Willebrand Disease – HFA
Hemophilia Federation of America (HFA) posted on LinkedIn:
”This year marks 100 years since Finnish physician Erik von Willebrand first described von Willebrand disease (vWD), the most common inherited bleeding disorder.
As we reflect on a century of progress, continued education and patient-centered insights remain essential to improving outcomes.
At Symposium New Orleans, HFA will feature sessions focused on vWD, including:
- ‘Understanding Your vWD Type: What It Means for You Across the Lifespan,’ featuring Nicoletta C. Machin.
- ‘Listening to People with von Willebrand Disease and Their Caregivers: Insights from the PIVOT-vWD US Patient-Reported Evidence and Insights Program’ featuring Sam Bristow, Co-founder and CEO of DHT Health
Register to join the conversation.”
Hemophilia Federation of America/LinkedIn
Keep up with Hemostasis Today.
-
May 18, 2026, 16:35Abdurrahmaan Ali Suei Elbuzidi: What is the Optimal Anticoagulation Monitoring Target in ECMO?
-
May 18, 2026, 16:34Serah N. Gathu: Gaining Valuable Updates on ACS Management at the Africa STEMI Conference
-
May 18, 2026, 16:34Mahmoud Alhariri: Apixaban in Hemodialysis-Treated Kidney Failure With Newly Diagnosed AF
-
May 18, 2026, 16:33Dimitrios Kontothanassis: The Role of Thermal Ablation in GSV Reflux Treatment – LIVE 2026
-
May 18, 2026, 16:32Michael Lichardi: New Publication on Complex Anticoagulation Management in Critical Care
-
May 18, 2026, 16:28Reza Shojaei: The Global Plasma-to-Ig Supply Chain
-
May 18, 2026, 16:01Abdul Mannan: The Hardest Conversations in Myelofibrosis
-
May 18, 2026, 15:57Bridging Innovation and Access at the WFH 2026 World Congress – South African Haemophilia Foundation
-
May 18, 2026, 15:55Pierre François Sabouret: Network Meta-Analysis of Antithrombotic Therapy in Ischemic Stroke Patients